| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Revenue | $129.7M | +81.4% |
| Cost of Revenue | $74.1M | +92.6% |
| Gross Profit | $55.6M | +68.3% |
| R&D Expense | $17.7M | +59.2% |
| SG&A Expense | $34.5M | +65.9% |
| Operating Income | -$5.0M | -50.2% |
| Income Tax | $1.8M | +839.5% |
| Net Income | -$5.4M | -32.6% |
| EPS (Basic) | -$0.16 |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.2M | +76.8% |
| Accounts Receivable | $26.3M | +94.3% |
| Inventory | $37.7M | +150.2% |
| Current Assets | $90.0M | +108.6% |
| Total Assets | $137.4M | +89.3% |
| Current Liabilities | $35.5M | +55.4% |
| Long-term Debt | $14.3M | +545.9% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.4M | -318.8% |
| Capital Expenditures | $2.1M | +170.5% |
| Investing Cash Flow | -$25.7M | -3188.3% |
| Financing Cash Flow | $42.6M | +2995.1% |
| Free Cash Flow | -$11.5M | -427.6% |
| -14.3% |
| EPS (Diluted) | -$0.16 | -14.3% |
| Total Liabilities |
| $57.5M |
| +117.1% |
| Stockholders' Equity | $79.9M | +73.3% |